A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data
2005 ◽
Vol 83
(3)
◽
pp. 804-807
◽
Keyword(s):
Keyword(s):
2002 ◽
Vol 77
(1)
◽
pp. 107-113
◽
2013 ◽
Vol 16
(7)
◽
pp. 951-961
◽
Keyword(s):
2016 ◽
Vol 19
(5)
◽
pp. 515-525
◽
2021 ◽
Vol 8
(2)
◽
pp. 163